Reversible neurotoxicity with combined lithium-haloperidol administration

Area of Science:

• Neuropharmacology
• Clinical Toxicology

Background:

• The co-administration of lithium and haloperidol is common in psychiatric practice.
• Concerns persist regarding potential adverse interactions, particularly neurotoxicity.

Observation:

• A case illustrates significant neurotoxicity despite low to moderate doses of lithium and haloperidol.
• Clinical presentation necessitated distinguishing neurotoxicity from exacerbation of psychotic symptoms.

Findings:

• Neurotoxicity can manifest insidiously, mimicking psychosis relapse.
• Electroencephalography (EEG) aids in diagnosing and monitoring these lithium-haloperidol-induced reactions.
• Potential mechanisms involve complex neurochemical pathways and interactions with various neuroleptics.

Implications:

• Clinicians must maintain a high index of suspicion for neurotoxicity in patients on combined lithium and haloperidol therapy.
• EEG monitoring can be a valuable tool for early detection and management.
• Further research into interaction mechanisms is warranted to optimize patient safety.